ALLO R&D Expense Growth
Allogene Therapeutics Inc · R&D Expense Growth
ALLO R&D Expense Growth
Latest reported-21.92%period ending
ALLO FY R&D Growth (YoY) (0.00% → -21.92%)
Latest values, visible window
High-resolution chart · PNG
ALLO r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -21.9174% | |
| -20.8366% | |
| -5.2549% | |
| 16.4464% | |
| 14.0885% | |
| 33.5227% | |
| -4.8235% | |
| 0% | |
| 0% |